Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$411M |
| 2 |
Microsoft
MSFT
|
+$309M |
| 3 |
ExxonMobil
XOM
|
+$258M |
| 4 |
Johnson & Johnson
JNJ
|
+$221M |
| 5 |
GE Aerospace
GE
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$58.7M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$57.9M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$54.7M |
| 4 |
Stellantis
STLA
|
+$25.2M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.83% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Consumer Staples | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QUOT
1926
DELISTED
Quotient Technology Inc
QUOT
| $958K | ﹤0.01% |
93,700
+23,400
| +33% | +$178K |
|
1927
Qualys
QLYS
$6.78B
| $956K | ﹤0.01% |
39,100
+7,300
| +23% | +$189K |
|
|
NTRI
1928
DELISTED
NutriSystem, Inc.
NTRI
| $955K | ﹤0.01% |
47,400
+8,900
| +23% | +$176K |
|
|
AMTG
1929
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $955K | ﹤0.01% |
73,800
+29,600
| +67% | +$346K |
|
|
ATRI
1930
DELISTED
Atrion Corp
ATRI
| $953K | ﹤0.01% |
2,502
+902
| +56% | +$341K |
|
1931
Gogo Inc
GOGO
$377M
| $952K | ﹤0.01% |
89,400
+15,600
| +21% | +$198K |
|
1932
Frontline
FRO
$9.02B
| $949K | ﹤0.01% |
116,219
+22,086
| +23% | +$213K |
|
|
CPLA
1933
DELISTED
Capella Education Company
CPLA
| $945K | ﹤0.01% |
18,600
+3,400
| +22% | +$157K |
|
|
BGC
1934
DELISTED
General Cable Corporation
BGC
| $944K | ﹤0.01% |
80,100
+14,800
| +23% | +$151K |
|
1935
TriCo Bancshares
TCBK
$1.86B
| $941K | ﹤0.01% |
38,300
+6,200
| +19% | +$157K |
|
|
HTO
1936
H2O America
HTO
$2.65B
| $939K | ﹤0.01% |
26,700
+4,600
| +21% | +$155K |
|
1937
Douglas Dynamics
PLOW
$967M
| $936K | ﹤0.01% |
42,100
+6,800
| +19% | +$137K |
|
1938
Universal Insurance Holdings
UVE
$1.18B
| $936K | ﹤0.01% |
54,400
+9,700
| +22% | +$180K |
|
1939
Inovio Pharmaceuticals
INO
$93M
| $935K | ﹤0.01% |
9,267
+1,734
| +23% | +$134K |
|
1940
Customers Bancorp
CUBI
$2.82B
| $932K | ﹤0.01% |
40,900
+7,800
| +24% | +$186K |
|
|
RAVN
1941
DELISTED
Raven Industries Inc
RAVN
| $929K | ﹤0.01% |
60,100
+11,300
| +23% | +$171K |
|
1942
Heron Therapeutics
HRTX
$63.5M
| $925K | ﹤0.01% |
50,400
+9,200
| +22% | +$182K |
|
1943
Lexicon Pharmaceuticals
LXRX
$1.04B
| $923K | ﹤0.01% |
79,614
+13,500
| +20% | +$142K |
|
|
SCLN
1944
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $922K | ﹤0.01% |
86,500
+14,200
| +20% | +$126K |
|
|
AHT
1945
Ashford Hospitality Trust
AHT
$20.2M
| $921K | ﹤0.01% |
152
+30
| +25% | +$163K |
|
|
ATW
1946
DELISTED
Atwood Oceanics
ATW
| $920K | ﹤0.01% |
103,850
+20,250
| +24% | +$153K |
|
|
ILG
1947
DELISTED
ILG, Inc Common Stock
ILG
| $918K | ﹤0.01% |
65,850
+13,150
| +25% | +$170K |
|
1948
Kelly Services Class A
KELYA
$566M
| $915K | ﹤0.01% |
49,500
+8,900
| +22% | +$148K |
|
|
TWOU
1949
DELISTED
2U Inc
TWOU
| $915K | ﹤0.01% |
1,400
+277
| +25% | +$176K |
|
|
UTEK
1950
DELISTED
Ultratech Inc.
UTEK
| $914K | ﹤0.01% |
43,400
+8,000
| +23% | +$158K |
|
Similar funds
Swiss National Bank's Q1 2016 Portfolio in Review
As of Q1 2016, Swiss National Bank held 2,649 positions worth $54.5B, up 32% from $41.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Swiss National Bank deployed $13.6B of net new capital in Q1 2016, opening 6 new positions and adding to 2,585 existing holdings. Its largest new stake was Ferrari: 823,472 shares worth $32.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Stellantis, an estimated $25.2M trimmed.
- Swiss National Bank's largest Q1 2016 buy was Ferrari: 823,472 shares worth $32.9M.
- Swiss National Bank added most to Apple in Q1 2016, an estimated $411M increase.
- Swiss National Bank's biggest Q1 2016 reduction was Stellantis, cutting an estimated $25.2M.
- Swiss National Bank fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $58.7M.
- Swiss National Bank's ten largest holdings make up 15% of its $54.5B portfolio in Q1 2016.
- Swiss National Bank opened 6 new positions and closed 38 in Q1 2016.
- Swiss National Bank's portfolio value rose 32% quarter-over-quarter to $54.5B.
Based on Swiss National Bank's 13F filing for Q1 2016, filed 4 May 2016.